According to a newly published market research report by 24LifeSciences, global Triage B-Type Natriuretic Peptide Testing market was valued at USD 786.2 million in 2023 and is projected to reach USD 1.24 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.8% during the forecast period 2024–2030.
Triage B-Type Natriuretic Peptide Testing is a critical diagnostic...
The global healthcare diagnostics industry is witnessing substantial transformation due to the increasing burden of cardiovascular disorders and the growing need for rapid disease detection solutions. Biomarker-based diagnostic technologies are gaining strong traction across hospitals, diagnostic laboratories, and point-of-care settings because of their ability to support early intervention and...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek